Page last updated: 2024-10-28

ibudilast and Peripheral Nerve Injury

ibudilast has been researched along with Peripheral Nerve Injury in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Ibudilast is a phosphodiesterase inhibitor with anti-inflammatory activity, but its effect on activated microglia in chronic neuropathic pain is poorly understood."1.48Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline. ( Asaki, T; Fujita, M; Hasegawa, M; Omachi, S; Rokushima, M; Sakaguchi, G; Shinohara, S; Tamano, R; Yogo, E; Yoneda, S, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, M1
Tamano, R1
Yoneda, S1
Omachi, S1
Yogo, E1
Rokushima, M1
Shinohara, S1
Sakaguchi, G1
Hasegawa, M1
Asaki, T1

Other Studies

1 other study available for ibudilast and Peripheral Nerve Injury

ArticleYear
Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline.
    European journal of pharmacology, 2018, Aug-15, Volume: 833

    Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Hyperalgesia; Injections, Spin

2018